Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 12.0B | 12.4B | 12.1B | 11.8B |
Cost of revenue | 4.5B | 4.8B | 4.4B | 4.2B |
Gross profit | 7.5B | 7.6B | 7.7B | 7.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 3.5B | 4.0B | 3.9B | 3.9B |
Operating income | 902.3M | 1.2B | 1.4B | 1.4B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 31.3M | 38.5M | 36.8M | 33.1M |
Other income expense | — | — | — | — |
Pretax income | 1.0B | 434.2M | 1.6B | 1.6B |
Tax provision | 746.3M | 58.1M | 458.3M | 428.9M |
Net income | 301M | 376.1M | 1.2B | 1.1B |
Basic EPS | — | 1.8 | 6.1 | 5.9 |
Diluted EPS | — | 1.8 | 6.1 | 5.9 |
Basic average shares | — | 190.1M | 190.2M | 190.2M |
Diluted average shares | — | 191.1M | 190.9M | 190.8M |
EBITDA | 1.6B | 2.0B | 2.2B | 2.1B |
Net income from continuing op. | — | — | — | — |
Minority interests | -9.6M | -28.3M | -3M | -18.8M |
Preferred stock dividends | 0 | 0 | 0 | 0 |